Table 1 Baseline characteristics of the study population.
Variable | Total DILI (N = 164) | Normal range |
|---|---|---|
Male, N(%) | 40 (24.4) | |
Age (years) | 50.00 (42.00, 56.00) | |
Smoking, N(%) | 24 (14.6) | |
Drinking, N(%) | 20 (12.2) | |
Hypersensitivity history, N(%) | 29 (17.7) | |
Hypertension, N(%) | 26 (15.9) | |
Dyslipidemia, N(%) | 59 (36.0) | |
Diabetes, N(%) | 14 (8.5) | |
WBC count (109/L) | 4.98 (3.94, 6.47) | 3.50–9.50 |
Neutrophil (109/L) | 2.74 (1.96, 3.59) | 1.80–6.30 |
Lymphocyte (109/L) | 1.69 (1.24, 2.19) | 1.10–3.20 |
Hemoglobin (g/L) | 128.00 (120.00, 140.00) | 115–150 |
Platelet (109/L) | 201.00 (164.00, 253.00) | 125–350 |
RDW (%) | 14.30 (13.10, 15.83) | 11.0–14.0 |
MCV (fL) | 89.90 (86.40, 93.30) | 82–100 |
AST (IU/L) | 117.80 (46.55,230.60) | 13.0–35.0 |
ALT (IU/L) | 164.35 (55.03,330.85) | 7.0–40.0 |
TBIL (μmol/L) | 29.40 (13.70,122.13) | 0.0–6.8 |
ALP (IU/L) | 121.90 (96.80,189.78) | 35.0–100.0 |
GGT (IU/L) | 147.65(77.40,275.53) | 7.0–45.0 |
Globulin (g/L) | 28.40 (24.60,31.85) | 20.0–40.0 |
TBA (μmol/L) | 25.60 (8.20,136.45) | 0–10 |
PT (s) | 11.45(10.80,12.40) | 9.0–13.0 |
INR | 0.99(0.93, 1.06) | 0.8–1.2 |